Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: a report from an International DLBCL Rituximab-CHOP Consortium Program study.

Xu Monette, Zy; Wu, L; Visco, C; Tai, Yc; Tzankov, A; Liu, Wm; Montes Moreno, S; Dybkær, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, Kl; Hsi, Ed; Zhao, Xf; Choi, Ww; Zhao, X; van Krieken, Jh; Huang, Q; Huh, J; Ai, W; Ponzoni, Maurilio; Ferreri, Aj; Zhou, F; Kahl, Bs; Winter, Jn; Xu, W; Li, J; Go, Rs; Li, Y; Piris, Ma; Møller, Mb; Miranda, Rn; Abruzzo, Lv; Medeiros, Lj; Young, K. H.